SubsidieMeestersHydrogel Biodegradable Ureteral Stent
Hydrustent is a biodegradable stent designed to prevent complications and eliminate the need for removal procedures, aiming to improve patient outcomes and reduce healthcare costs significantly.
Projectdetails
Introduction
Hydrumedical S.A. (HYD) team is composed of a urologist and biomaterials scientists that will revolutionize the treatment of ureteral disorders.
Product Overview
Hydrustent is a biodegradable, hydrogel-based, soft, lubricated, and flexible stent. These properties prevent bacterial adhesion (over 80% of the stent-related complications) and encrustation development.
Current Challenges
Nowadays, the application of stents requires a second removal procedure, which is a burden for patients and healthcare systems.
Benefits of Hydrustent
Hydrustent is homogeneously degraded by the urine flow within 7-10 days, eliminating the need for further interventions for its removal.
Health and Economic Impact
- Hydrustent will bring huge health benefits for patients.
- It is expected to reduce treatment costs by up to 60%, resulting in savings of approximately 4.3 billion for the health system in the EU and US.
Market Validation and Future Plans
Validated by the urology community, the global Ureteral Stents Market is projected to raise around 604 million by 2030. If the Hydrustent project is successfully implemented, we intend to reach the EU market in 2024 with profits amounting to 25 million, five years after the product launch.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.522.762 |
| Totale projectbegroting | € 2.225.375 |
Tijdlijn
| Startdatum | 1-12-2023 |
| Einddatum | 30-11-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- HYDRUMEDICAL SApenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary IncontinenceDeveloping UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity. | EIC Accelerator | € 2.499.999 | 2023 | Details |
A life-changing PREssure Sensor System for UROdynamics to solve global urinary storage and voiding problemsPRESSURO is a groundbreaking bladder pressure sensor system that enables continuous, natural measurement for improved diagnosis and treatment of urinary dysfunction in millions of patients. | EIC Accelerator | € 2.499.000 | 2022 | Details |
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosisVesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term EffectiveHy2Care develops a regenerative injectable hydrogel for cartilage repair, promoting natural healing and long-lasting joint health while preventing osteoarthritis. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Breakthrough dual-action OTC tablet for treatment and prevention of both bacterial and fungal vaginitisGedea aims to commercialize pHyph, an antimicrobial-free pessary for treating and preventing BV and VVC, addressing a significant medical need while avoiding antibiotic resistance. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary Incontinence
Developing UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity.
A life-changing PREssure Sensor System for UROdynamics to solve global urinary storage and voiding problems
PRESSURO is a groundbreaking bladder pressure sensor system that enables continuous, natural measurement for improved diagnosis and treatment of urinary dysfunction in millions of patients.
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis
VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.
Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective
Hy2Care develops a regenerative injectable hydrogel for cartilage repair, promoting natural healing and long-lasting joint health while preventing osteoarthritis.
Breakthrough dual-action OTC tablet for treatment and prevention of both bacterial and fungal vaginitis
Gedea aims to commercialize pHyph, an antimicrobial-free pessary for treating and preventing BV and VVC, addressing a significant medical need while avoiding antibiotic resistance.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Polymer-based Stealth Coating of Hemocompatible and Absorbable StentsThe StealthStent project aims to create a resorbable stent for pediatric congenital heart disease, reducing foreign body reactions and improving treatment outcomes for children and adults. | EIC Transition | € 2.495.679 | 2025 | Details |
Stent delivery deviceVenous Stent B.V. ontwikkelt een innovatief delivery device voor nauwkeurige plaatsing van de revolutionaire WStent. | Mkb-innovati... | € 20.000 | 2022 | Details |
The hydrocup: a hollow electrospun scaffold for in vivo cell-laden hydrogel deliveryDeveloping a hollow electrospun scaffold for localized delivery of viable stem cells to enhance cytokine secretion and support cardiac regeneration, with plans for commercialization. | ERC Proof of... | € 150.000 | 2022 | Details |
Regenerative Stenting for Osteoporotic Vertebral Fracture RepairRESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair. | ERC Consolid... | € 2.039.473 | 2024 | Details |
Ultra-tunable and Bio-stable Antibacterial Coating (UBAC)Preimure ontwikkelt een innovatieve antibacteriële coating voor implantaten om infecties te voorkomen, revisieoperaties te verminderen en de zorgkosten te verlagen. | Mkb-innovati... | € 20.000 | 2022 | Details |
Polymer-based Stealth Coating of Hemocompatible and Absorbable Stents
The StealthStent project aims to create a resorbable stent for pediatric congenital heart disease, reducing foreign body reactions and improving treatment outcomes for children and adults.
Stent delivery device
Venous Stent B.V. ontwikkelt een innovatief delivery device voor nauwkeurige plaatsing van de revolutionaire WStent.
The hydrocup: a hollow electrospun scaffold for in vivo cell-laden hydrogel delivery
Developing a hollow electrospun scaffold for localized delivery of viable stem cells to enhance cytokine secretion and support cardiac regeneration, with plans for commercialization.
Regenerative Stenting for Osteoporotic Vertebral Fracture Repair
RESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair.
Ultra-tunable and Bio-stable Antibacterial Coating (UBAC)
Preimure ontwikkelt een innovatieve antibacteriële coating voor implantaten om infecties te voorkomen, revisieoperaties te verminderen en de zorgkosten te verlagen.